Individuals thought to be at higher risk would include any patient with a first degree relative with idiopathic PAH, a genetic-mutation associated with PAH (i.e., BMP4), an underlying connective tissue disorder (i.e., scleroderma), known congenital heart disease, or HIV infection. The gene discussed is BMP4; the disease is pulmonary arterial hypertension.